DI FRANCESCO, JACOPO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 5.482
EU - Europa 2.649
AS - Asia 1.152
SA - Sud America 96
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 9.403
Nazione #
US - Stati Uniti d'America 5.392
IT - Italia 594
DE - Germania 584
CN - Cina 394
SG - Singapore 394
SE - Svezia 345
IE - Irlanda 281
RU - Federazione Russa 219
GB - Regno Unito 159
UA - Ucraina 153
HK - Hong Kong 147
FI - Finlandia 118
CA - Canada 83
BR - Brasile 73
VN - Vietnam 64
FR - Francia 50
IN - India 43
AT - Austria 37
BE - Belgio 31
DK - Danimarca 30
ID - Indonesia 27
TR - Turchia 27
JP - Giappone 16
NL - Olanda 15
CL - Cile 14
IR - Iran 12
ES - Italia 8
EU - Europa 7
GE - Georgia 5
IQ - Iraq 5
DO - Repubblica Dominicana 4
EC - Ecuador 4
PK - Pakistan 4
PT - Portogallo 4
RO - Romania 4
AU - Australia 3
NG - Nigeria 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GR - Grecia 2
HU - Ungheria 2
KR - Corea 2
MU - Mauritius 2
NO - Norvegia 2
PH - Filippine 2
PY - Paraguay 2
RS - Serbia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MX - Messico 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 9.403
Città #
Ann Arbor 1.487
Chandler 410
Fairfield 392
Woodbridge 392
Frankfurt am Main 364
Singapore 338
Wilmington 337
Dublin 272
Ashburn 263
Houston 254
Milan 208
Santa Clara 178
Jacksonville 174
Dearborn 160
Seattle 150
Hong Kong 145
New York 137
Cambridge 132
Princeton 113
Munich 86
Helsinki 84
Nanjing 79
Shanghai 62
Lawrence 47
Altamura 38
Dong Ket 37
Vienna 33
Lachine 30
Beijing 29
Jakarta 27
Boardman 26
Brussels 24
Andover 22
Grafing 21
Ottawa 21
Monza 20
San Diego 20
Guangzhou 19
Jinan 19
Nanchang 19
Pune 19
Fremont 18
Rome 17
Los Angeles 15
Shenyang 15
Zhengzhou 15
Kocaeli 14
Toronto 14
Santiago 13
Changsha 12
Falls Church 12
London 12
São Paulo 12
Tianjin 12
Hebei 11
Hangzhou 10
Lissone 10
Moscow 10
Edmonton 9
Leawood 9
Monmouth Junction 9
Nuremberg 9
Jiaxing 8
Mountain View 8
Bari 7
Dallas 7
Detroit 7
Florence 7
Kunming 7
Turin 7
Chicago 6
Segrate 6
Sesto San Giovanni 6
Taizhou 6
Auburn Hills 5
Brugherio 5
Dalmine 5
Hefei 5
Ningbo 5
University Park 5
Bergamo 4
Bologna 4
Brooklyn 4
Lappeenranta 4
Leipzig 4
Norwalk 4
Peschiera Borromeo 4
Quito 4
Rho 4
Samaná 4
Southwark 4
Squillace 4
Stockholm 4
Tokyo 4
Truyes 4
Verona 4
Abuja 3
Alpharetta 3
Bonndorf 3
Borgo Val di Taro 3
Totale 7.134
Nome #
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 375
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 337
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 315
Cardiac and neuronal HCN channelopathies 285
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 283
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 277
Effect of the ketogenic diet in excitable tissues 250
Generation and validation of algorithms to identify subjects with dementia using administrative data 247
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 242
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 226
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 207
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 207
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 197
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 193
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 192
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 192
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 190
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 189
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 186
Brain targets: can you believe your own eyes? 177
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 174
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 168
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 166
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 164
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 164
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 163
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 161
Cerebral amyloid angiopathy-related inflammation: an emerging disease 160
A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation 160
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 155
Autoimmune encephalopathy in Graves' disease: Remission after total thyroidectomy 154
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 154
HCN1 novel mutations in familiar generalized epilepsy 153
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 151
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 146
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study 144
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 142
Epilptic seizures and psychogenic non-epileptic seizures 139
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 135
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines 131
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 130
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 128
Complicanze neurologiche di malattie internistiche 126
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 122
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 113
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 112
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 111
Cerebral Amyloid Angiopathy-Related Inflammation 109
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 107
LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS 97
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 94
Neurological soft signs are increased in migraine without aura: relationship with the affective status 91
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 84
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 82
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 80
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 79
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 78
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 71
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 70
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 63
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 60
Epilepsy in Cerebral Amyloid Angiopathy: an observational retrospective study of a large population 58
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 34
Totale 9.950
Categoria #
all - tutte 34.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020528 0 0 0 0 0 0 0 105 149 121 117 36
2020/20211.643 75 88 181 161 121 140 147 174 147 151 109 149
2021/20221.015 119 111 115 84 84 94 34 46 50 48 78 152
2022/20231.695 162 472 158 188 124 237 34 82 167 11 25 35
2023/20241.056 27 62 49 69 152 257 162 56 78 11 17 116
2024/20251.355 135 283 156 97 216 180 250 38 0 0 0 0
Totale 9.950